Dana L. Schalk

703 citations
30 papers · 534 indexed · h-index 13
Topics
CAR-T cell therapy research (20 papers)Immunotherapy and Immune Responses (11 papers)Monoclonal and Polyclonal Antibodies Research (10 papers)

In The Last Decade

Dana L. Schalk

30 papers receiving 531 citations

Peers

Dana L. Schalk
Comparison fields: 5 of 64
  • Oncology 294
  • Immunology 214
  • Molecular Biology 170
  • Radiology, Nuclear Medicine and Imaging 90
  • Pathology and Forensic Medicine 87
Replace Shengzhi Wang with:
Shengzhi Wang China
Alexandra Treschow Sweden
Maria Ormhøj Denmark
Hélène Haegel France
Sun Kil Choi South Korea
Élodie Picarda France
Selena Lorrey United States
James Nevin United States
Thomas C. Manning United States
Solange Landreville Canada
Dana L. Schalk relative to Shengzhi Wang China Shengzhi Wang's profile →
Citations per field
00.5×4.1×
Shengzhi Wang · 1×
Citations per year

Countries citing papers authored by Dana L. Schalk

Since Specialization
Citations

This map shows the geographic impact of Dana L. Schalk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana L. Schalk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana L. Schalk more than expected).

Fields of papers citing papers by Dana L. Schalk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana L. Schalk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana L. Schalk. The network helps show where Dana L. Schalk may publish in the future.

Co-authorship network of co-authors of Dana L. Schalk

This figure shows the co-authorship network connecting the top 25 collaborators of Dana L. Schalk. A scholar is included among the top collaborators of Dana L. Schalk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana L. Schalk. Dana L. Schalk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 12
3 5
4 21
5 13
6 8
7 14
8 5
9 2
10 7
11 88
12 99
13 17
14 1
15 32
16 31
17 2
18 11
19 44
20 7

About Dana L. Schalk

Dana L. Schalk is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 30 papers that have together received 534 indexed citations. Recurring topics across this work include CAR-T cell therapy research (20 papers), Immunotherapy and Immune Responses (11 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). The work is most often cited by research in Oncology (294 citations), Immunology (214 citations) and Pathology and Forensic Medicine (87 citations). Dana L. Schalk has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Lawrence G. Lum, Archana Thakur, Fazlul H. Sarkar, Abhinav Deol, Olivia M. Merkel, David Bassett, Yuran Xie, Venkatareddy Nadithe, Ayşe Kılıç and Amit Bar‐Or. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026